ALCOHOL, BRAIN METABOLISM AND BENZODIAZEPINE RECEPTOR BINDING
ALCOHOL, BRAIN METABOLISM AND BENZODIAZEPINE RECEPTOR BINDING
批准号:
6097661
负责人:
SID GILMAN
金额:
$2.17万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
关键词:
alcoholism /alcohol abuse benzodiazepine receptor brain disorder diagnosis brain mapping brain metabolism cerebellar disorders cerebellum ethanol frontal lobe /cortex glucose metabolism human middle age (35-64) human old age (65+) human subject magnetic resonance imaging mental disorder diagnosis neural degeneration neuropharmacology neuropsychological tests neuropsychology positron emission tomography receptor binding speech
中文摘要
死后的神经病理学研究表明,
酒精的摄入减少了上级额叶神经元的数量
大脑皮层的区域。 死后组织的生化研究
长期酒精依赖的受试者表明,GABA-
A/苯二氮卓类(BDZ)受体可能在额叶皮层减少
和海马体,但大脑皮层的其他区域没有。 利用
正电子发射断层扫描(PET)与[11 C]氟马西尼,我们建议
确定BDZ受体的密度是否降低,
额叶皮层在生活中的慢性酒精依赖的人,
与一组年龄和性别相似的正常对照组相比,
分布。 使用PET与[18F]氟脱氧葡萄糖在相同的
受试者,我们将检查局部脑葡萄糖代谢率
(LCMRG),并比较BDZ受体结合的分布与
LCMRG模式。 我们预计在慢性酒精依赖者中
患者BDZ受体密度降低,
LCMRG在大脑皮层的上级额叶区域。 我们将使用
神经心理学测试不能研究额叶功能,
患者,并预期发现性能降低,
与BDZ受体和LCMRG的减少水平相关,
上级额叶皮层
神经病理学研究还表明,长期摄入过量
乙醇减少了小脑上级蚓部的神经元数量,
小脑,即使对于没有小脑疾病症状的患者也是如此
生活中 慢性肺心病死后组织的生化研究
酒精依赖的受试者表明,BDZ受体结合可能
在小脑中减少。 我们建议使用[11C]氟马西尼,
[18 F]氟脱氧葡萄糖与PET检查BDZ受体的密度
和临床症状性LCMRG患者的模式
酒精性小脑变性(ACD),慢性酒精依赖性
无小脑变性证据且正常的患者
年龄和性别分布相似的对照组。 为了检测
任何生物化学变化所造成的解剖连接之间
大脑皮层和小脑,我们也建议研究患者
慢性小脑退化(显性遗传)
橄榄体脑桥小脑萎缩,OPCA)使用相同的PET探头,
确定BDZ结合中的局灶性干扰是否会降低LCMRG
局限于小脑前上级。 我们预计会发现
BDZ结合减少和LCMRG减少仅限于酒精和酒精中,
无ACD的依赖性患者,BDZ结合减少,
LCMRG广泛分布于小脑,但不局限于大脑皮质,
OPCA患者
英文摘要
Postmortem neuropathological studies indicate that excessive chronic
intake of ethanol decreases the number of neurons in the superior frontal
region of the cerebral cortex. Biochemical studies on postmortem tissue
of chronically alcohol-dependent subjects suggest that GABA-
A/benzodiazepine (BDZ) receptors may be decreased in the frontal cortex
and hippocampus but not in other areas of the cerebral cortex. Utilizing
positrons emission tomography (PET) with [11C]Flumazenil, we propose to
determine whether the density of BDZ receptors is reduced within the
frontal cortex in living chronically alcohol-dependent persons as
compared with a group of normal control subjects with similar age and sex
distributions. Using PET with [18F]fluorodeoxyglucose in the same
subjects, we will examine the local cerebral metabolic rate for glucose
(LCMRG) and compare the distribution of BDZ receptor binding with the
pattern of LCMRG. We anticipate finding in chronically alcohol-dependent
patients a decrease in the density of BDZ receptors and a decrease in
LCMRG in the superior frontal region of the cerebral cortex. We will use
neuropsychological tests t study frontal lobe function in the same
patients, and anticipate finding that performance is diminished and
correlated with the level of reduction of BDZ receptors and of LCMRG in
the superior frontal cortex.
Neuropathological studies also demonstrate that excessive chronic intake
of ethanol decreases the number of neurons in the superior vermis of the
cerebellum, even in patients who had no symptoms of cerebellar disorder
in life. Biochemical studies on postmortem tissue of chronically
alcohol-dependent subjects suggest that BDZ receptor binding may be
decreased in the cerebellum. We propose to use [11C]flumazenil and
[18F]fluorodeoxyglucose with PET to examine the density of BDZ receptors
and the pattern of LCMRG in patients with clinically symptomatic
alcoholic cerebellar degeneration (ACD), in chronically alcohol-dependent
patients without evidence of cerebellar degeneration and in normal
control subjects of similar age and sex distribution. In order to detect
any biochemical changes resulting from the anatomical connections between
the cerebral cortex and the cerebellum, we also propose to study patients
with a chronic cerebellar degeneration (dominantly inherited
olivopontocerebellar atrophy, OPCA) using the same PET probes to
determine whether focal disturbances in BDZ binding and decrease LCMRG
confined to the anterior superior cerebellum. We anticipate finding
decreased BDZ binding and decreased LCMRG confined to and in alcohol-
dependent patients without ACD, and reduced BDZ binding and decreased
LCMRG widely i the cerebellum but not focally in the cerebral cortex in
patients with OPCA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEUROCHEMICAL BASIS OF SLEEP DISORDERS IN NEURODEGENERATIVE DISEASES
-
批准号:7603709
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2007
-
负责人:SID GILMAN
-
依托单位:
PATHOGENESIS AND DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY
-
批准号:7603764
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2007
-
负责人:SID GILMAN
-
依托单位:
Conference on the Diagnosis of Multiple System Atrophy
-
批准号:7113588
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2006
-
负责人:SID GILMAN
-
依托单位:
PATHOGENESIS AND DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY
-
批准号:7376596
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2006
-
负责人:SID GILMAN
-
依托单位:
NEUROCHEMICAL BASIS OF SLEEP DISORDERS IN NEURODEGENERATIVE DISEASES
-
批准号:7376508
-
项目类别:
-
资助金额:$5.21万
-
财政年份:2006
-
负责人:SID GILMAN
-
依托单位:
NEUROCHEMICAL BASIS OF SLEEP DISORDERS IN NEURODEGENERATIVE DISEASES
-
批准号:7199827
-
项目类别:
-
资助金额:$3.4万
-
财政年份:2005
-
负责人:SID GILMAN
-
依托单位:
ADIMINISTRATIVE CORE
-
批准号:6933382
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2005
-
负责人:SID GILMAN
-
依托单位:
PATHOGENESIS AND DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY
-
批准号:7199924
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2005
-
负责人:SID GILMAN
-
依托单位:
Neurochemical Basis of Sleep Disorders in Neurodegenerative Diseases
-
批准号:7039799
-
项目类别:
-
资助金额:$6.76万
-
财政年份:2004
-
负责人:SID GILMAN
-
依托单位:
Longitudinal Course of MSA
-
批准号:7990740
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2003
-
负责人:SID GILMAN
-
依托单位:
MONOAMINERGIC PATHWAYS IN NEURODEGENERATIVE DISEASES
-
批准号:6315624
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2000
-
负责人:SID GILMAN
-
依托单位:
MONOAMINERGIC PATHWAYS IN NEURODEGENERATIVE DISEASES
-
批准号:6216977
-
项目类别:
-
资助金额:$22.35万
-
财政年份:1999
-
负责人:SID GILMAN
-
依托单位:
ALCOHOL, BRAIN METABOLISM AND BENZODIAZEPINE RECEPTOR BINDING
-
批准号:6218624
-
项目类别:
-
资助金额:$2.17万
-
财政年份:1999
-
负责人:SID GILMAN
-
依托单位:
MONOAMINERGIC PATHWAYS IN NEURODEGENERATIVE DISEASES
-
批准号:6203631
-
项目类别:
-
资助金额:$22.35万
-
财政年份:1999
-
负责人:SID GILMAN
-
依托单位:
EXTRAPYAMIDAL DYSFUNCTION IN NEURODEGENERATIVE DISEASES
-
批准号:6204994
-
项目类别:
-
资助金额:$10.35万
-
财政年份:1999
-
负责人:SID GILMAN
-
依托单位:
BENZODIAZEPINE RECEPTORS IN NEURODEGENERATIVE DISEASES
-
批准号:6098199
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:SID GILMAN
-
依托单位:
BENZODIAZEPINE RECEPTORS IN NEURODEGENERATIVE DISEASES
-
批准号:6267437
-
项目类别:
-
资助金额:$18.57万
-
财政年份:1998
-
负责人:SID GILMAN
-
依托单位:
EXTRAPYAMIDAL DYSFUNCTION IN NEURODEGENERATIVE DISEASES
-
批准号:6112125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:SID GILMAN
-
依托单位:
BENZODIAZEPINE RECEPTORS IN NEURODEGENERATIVE DISEASES
-
批准号:6234208
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1997
-
负责人:SID GILMAN
-
依托单位:
Michigan Alzheimer's Disease Research Center
-
批准号:7446639
-
项目类别:
-
资助金额:$189.05万
-
财政年份:1997
-
负责人:SID GILMAN
-
依托单位:
海外基金